Melbourne: A newly identified “blood signature” may predict lung cancer risk more than five years before diagnosis, offering a potential pathway to earlier prevention, a study has revealed. Researchers Discover 14-Protein Blood Signature The findings, published in Cell, could help identify people who would benefit from preventative drugs, even before they receive a lung cancer.
